Mobile-health Network Solutions Class A (MNDR)
BiotechSign Signal Grade
Composite of clinical trial activity, dilution exposure, publications, short interest, and insider transactions — all from verified public filings.
Pipeline Overview
- Therapeutic Focus
- Biotech / Pharmasrc
Clinical Trial Activity
(ClinicalTrials.gov aggregate)
ClinicalTrials.gov aggregate as of 2026-10-13. ClinicalTrials.gov
Dilution Risk
CRITICAL DILUTION RISKDilution score: 86/100 (CRITICAL), 2.8 months cash
Derived from verified regulatory filings. Measures dilution exposure from warrants, convertibles, and offering history. DilutionWatch SEC-derived score
Short Interest
Short interest: 11.96% of float, squeeze risk: LOW
FINRA short sale data. FINRA short interest
Recent News & SEC Filings
- Mobile-health Network Solutions Advances AI-Powered Lab Data Analysis to Transform Clinical Decision-Making
- Mobile-health Network Solutions Announces Effective Date of Reverse Stock Split
- CORRECTION FROM SOURCE: Mobile-health Network Solutions Expands into Cybersecurity with Skylink-Contfinity Partnership, Launching OtterSG Bundled Solution for Clinics in Singapore
- Mobile-health Network Solutions Enters into Non-Binding Strategic Memorandum to Facilitate Up to US$100 Million in Private Equity Funding for AI-Powered Healthcare Expansion
- MNDR Lands $126M AI Data Center Deal — But 65% Ownership Shift Raises Big Questions
- Mobile-health Network Solutions Announces Acquisition of Additional 35MW AI Data Centre Capacity, Expanding Total Secured Capacity to 60MW
- Mobile-health Network Solutions Enters into Non-Binding US$119 Million Strategic Framework with Hector Capital to Acquire BIMA and M&M Helix, Accelerating AI-powered Healthcare Expansion across Asia and Africa
- Mobile-health Network Solutions and Dato' Stanley Ling Announce Strategic US$126 Million Investment to Build Phased 60 MW AI Data Center Campus
Headlines from public sources. BiotechSign does not endorse or verify linked content.
Get real-time catalyst alerts, analyst signals, dilution risk tracking, and full pipeline data for Mobile-health Network Solutions Class A.
Full MNDR Dashboard Sign Up FreePrimary Sources
This page reports only records present in the BiotechSign source payload as of the generation date. It does not infer drug efficacy, clinical outcome probability, approval odds, revenue, market size, or unreported regulatory events.